BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21725289)

  • 1. FGFR2 alterations in endometrial carcinoma.
    Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X
    Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma.
    Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR
    Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.
    Pallarés J; Velasco A; Eritja N; Santacana M; Dolcet X; Cuatrecasas M; Palomar-Asenjo V; Catasús L; Prat J; Matias-Guiu X
    Mod Pathol; 2008 Jun; 21(6):691-9. PubMed ID: 18469797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
    Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
    Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of unlabeled probes for the detection of fibroblast growth factor receptor 2 exons 7 and 12 mutations in endometrial carcinoma.
    Liu T; Willmore-Payne C; Wallander ML; Layfield LJ
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):341-6. PubMed ID: 21285871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous morules are functionally inert elements of premalignant endometrial neoplasia.
    Lin MC; Lomo L; Baak JP; Eng C; Ince TA; Crum CP; Mutter GL
    Mod Pathol; 2009 Feb; 22(2):167-74. PubMed ID: 19180120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
    Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
    Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
    Niikura H; Sasano H; Kaga K; Sato S; Yajima A
    Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
    Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
    Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.
    Cao QJ; Einstein MH; Anderson PS; Runowicz CD; Balan R; Jones JG
    Int J Gynecol Pathol; 2002 Apr; 21(2):147-54. PubMed ID: 11917224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters.
    Mitselou A; Ioachim E; Zagorianakou N; Kitsiou E; Vougiouklakis T; Agnantis NJ
    Eur J Gynaecol Oncol; 2004; 25(6):719-24. PubMed ID: 15597850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of expression of Notch protein members in normal and pathological endometrium.
    Cobellis L; Caprio F; Trabucco E; Mastrogiacomo A; Coppola G; Manente L; Colacurci N; De Falco M; De Luca A
    J Anat; 2008 Oct; 213(4):464-72. PubMed ID: 18691378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.